Global Multivalent Vaccines Market Analysis 2013-2018 and Forecast 2019-2024

Table of Contents

1 Industry Overview

• 1.1 Multivalent Vaccines Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Multivalent Vaccines
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Multivalent Vaccines Market by Type

• 3.1 By Type
  • 3.1.1 Conjugate Vaccines
  • 3.1.2 Inactivated and Subunit Vaccines
  • 3.1.3 Live Attenuated Vaccines
  • 3.1.4 Toxoid Vaccines
  • 3.1.5 Recombinant Vaccines
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Multivalent Vaccines GlaxoSmithKline, plc (U.K.) (Company Profile, Sales Data etc.)

• 4.2 Pfizer, Inc. (U.S.) (Company Profile, Sales Data etc.)
• 4.3 Merck & Co., Inc. (U.S.) (Company Profile, Sales Data etc.)
• 4.4 Sanofi Pasteur SA (France) (Company Profile, Sales Data etc.)
• 4.5 Astellas Pharma Inc. (Japan) (Company Profile, Sales Data etc.)
• 4.6 CSL Limited (Australia) (Company Profile, Sales Data etc.)
• 4.7 Emergent BioSolutions, Inc. (U.S.) (Company Profile, Sales Data etc.)
• 4.8 Johnson & Johnson (U.S.) (Company Profile, Sales Data etc.)
• 4.9 MedImmune, LLC (U.S.) (Company Profile, Sales Data etc.)
• 4.10 Serum Institute of India Pvt. Ltd. (India) (Company Profile, Sales Data etc.)
• 4.11 Bavarian Nordic (Denmark) (Company Profile, Sales Data etc.)
• 4.12 Mitsubishi Tanabe Pharma Corporation (Japan) (Company Profile, Sales Data etc.)
• 4.13 Daiichi Sankyo (Japan) (Company Profile, Sales Data etc.)
• 4.14 Protein Sciences Corporation (U.S.) (Company Profile, Sales Data etc.)
• 4.15 Panacea Biotec (India) (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Pediatrics
  • 6.1.2 Demand in Adults
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Multivalent Vaccines

Table Application Segment of Multivalent Vaccines

Table Global Multivalent Vaccines Market 2013-2024, by Application, in USD Million

Table Major Company List of Conjugate Vaccines

Table Major Company List of Inactivated and Subunit Vaccines

Table Major Company List of Live Attenuated Vaccines

Table Major Company List of Toxoid Vaccines

Table Major Company List of Recombinant Vaccines

Table Global Multivalent Vaccines Market 2013-2018, by Type, in USD Million

Table Global Multivalent Vaccines Market 2013-2018, by Type, in Volume

Table Global Multivalent Vaccines Market Forecast 2019-2024, by Type, in USD Million

Table Global Multivalent Vaccines Market Forecast 2019-2024, by Type, in Volume

Table GlaxoSmithKline, plc (U.K.) Overview List

Table Multivalent Vaccines Business Operation of GlaxoSmithKline, plc (U.K.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer, Inc. (U.S.) Overview List

Table Multivalent Vaccines Business Operation of Pfizer, Inc. (U.S.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merck & Co., Inc. (U.S.) Overview List

Table Multivalent Vaccines Business Operation of Merck & Co., Inc. (U.S.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanofi Pasteur SA (France) Overview List

Table Multivalent Vaccines Business Operation of Sanofi Pasteur SA (France) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Astellas Pharma Inc. (Japan) Overview List

Table Multivalent Vaccines Business Operation of Astellas Pharma Inc. (Japan) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table CSL Limited (Australia) Overview List

Table Multivalent Vaccines Business Operation of CSL Limited (Australia) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Emergent BioSolutions, Inc. (U.S.) Overview List

Table Multivalent Vaccines Business Operation of Emergent BioSolutions, Inc. (U.S.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Johnson & Johnson (U.S.) Overview List

Table Multivalent Vaccines Business Operation of Johnson & Johnson (U.S.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table MedImmune, LLC (U.S.) Overview List

Table Multivalent Vaccines Business Operation of MedImmune, LLC (U.S.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Serum Institute of India Pvt. Ltd. (India) Overview List

Table Multivalent Vaccines Business Operation of Serum Institute of India Pvt. Ltd. (India) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bavarian Nordic (Denmark) Overview List

Table Multivalent Vaccines Business Operation of Bavarian Nordic (Denmark) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Mitsubishi Tanabe Pharma Corporation (Japan) Overview List

Table Multivalent Vaccines Business Operation of Mitsubishi Tanabe Pharma Corporation (Japan) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Daiichi Sankyo (Japan) Overview List

Table Multivalent Vaccines Business Operation of Daiichi Sankyo (Japan) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Protein Sciences Corporation (U.S.) Overview List

Table Multivalent Vaccines Business Operation of Protein Sciences Corporation (U.S.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Panacea Biotec (India) Overview List

Table Multivalent Vaccines Business Operation of Panacea Biotec (India) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Multivalent Vaccines Sales Revenue 2013-2018, by Company, in USD Million

Table Global Multivalent Vaccines Sales Revenue Share, by Company, in USD Million

Table Global Multivalent Vaccines Sales Volume 2013-2018, by Company, in Volume

Table Global Multivalent Vaccines Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Multivalent Vaccines Demand Forecast 2019-2024, by Application, in USD Million

Table Multivalent Vaccines Demand Forecast 2019-2024, by Application, in Volume

Table Multivalent Vaccines Production 2013-2018, by Region, in USD Million

Table Multivalent Vaccines Production 2013-2018, by Region, in Volume

Table Global Multivalent Vaccines Market 2013-2018, by Region, in USD Million

Table Global Multivalent Vaccines Market Share 2013-2018, by Region, in USD Million

Table Global Multivalent Vaccines Market 2013-2018, by Region, in Volume

Table Global Multivalent Vaccines Market Share 2013-2018, by Region, in Volume

Table North America Multivalent Vaccines Market Size 2013-2018, by Country, in USD Million

Table North America Multivalent Vaccines Market Size 2013-2018, by Country, in Volume

Table Europe Multivalent Vaccines Market Size 2013-2018, by Country, in USD Million

Table Europe Multivalent Vaccines Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Multivalent Vaccines Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Multivalent Vaccines Market Size 2013-2018, by Country, in Volume

Table South America Multivalent Vaccines Market Size 2013-2018, by Country, in USD Million

Table South America Multivalent Vaccines Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Multivalent Vaccines Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Multivalent Vaccines Market Size 2013-2018, by Country, in Volume

Table Multivalent Vaccines Market Forecast 2019-2024, by Region, in USD Million

Table Multivalent Vaccines Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Multivalent Vaccines Market Growth 2013-2018, by Type, in USD Million

Figure Global Multivalent Vaccines Market Growth 2013-2018, by Type, in Volume

Figure North America Multivalent Vaccines Market Concentration, in 2018

Figure Europe Multivalent Vaccines Market Market Concentration, in 2018

Figure Asia-Pacific Multivalent Vaccines MMarket Concentration, in 2018

Figure South America Multivalent Vaccines Market Concentration, in 2018

Figure Middle East & Africa Multivalent Vaccines Market Concentration, in 2018

Figure Multivalent Vaccines Demand in Pediatrics, 2013-2018, in USD Million

Figure Multivalent Vaccines Demand in Pediatrics, 2013-2018, in Volume

Figure Multivalent Vaccines Demand in Adults, 2013-2018, in USD Million

Figure Multivalent Vaccines Demand in Adults, 2013-2018, in Volume

Figure North America Multivalent Vaccines Market Size and Growth 2013-2018, in USD Million

Figure North America Multivalent Vaccines Market Size and Growth 2013-2018, in Volume

Figure Europe Multivalent Vaccines Market Size and Growth 2013-2018, in USD Million

Figure Europe Multivalent Vaccines Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Multivalent Vaccines Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Multivalent Vaccines Market Size and Growth 2013-2018, in Volume

Figure South America Multivalent Vaccines Market Size and Growth 2013-2018, in USD Million

Figure South America Multivalent Vaccines Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Multivalent Vaccines Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Multivalent Vaccines Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview